Literature DB >> 12042436

Rice expressing lactoferrin and lysozyme has antibiotic-like properties when fed to chicks.

Brooke D Humphrey1, Ning Huang, Kirk C Klasing.   

Abstract

Two experiments were conducted to determine whether rice that has been genetically produced to express human lactoferrin (LF) or lysozyme (LZ) protects the intestinal tract similarly to subtherapeutic antibiotics (bacitracin + roxarsone; Antibiotics). Experiment 1 compared 10 corn-soy diets containing 20% of various proportions of LF, LZ or conventional rice (CONV). Chicks fed 5% LF + 10% LZ + 5% CONV had significantly better feed efficiency and thinner lamina propria in the duodenum than those fed 20% CONV. Experiment 2 compared five corn-soy diets containing experimental rice combinations totaling 15% rice. Chicks fed 10% LZ + 5% CONV or 5% LF + 10% LZ had significantly lower feed intake and significantly better feed efficiency than those fed 15% CONV. Chicks fed 10% LZ + 5% CONV, 5% LF + 10% LZ or Antibiotics had significantly greater villous height in the duodenum compared with chicks fed 15% CONV. The lamina propria of the ileum was thinner and contained fewer leukocytes in chicks fed 10% LZ + 5% CONV or Antibiotics compared with those fed 15% CONV. The results from these experiments demonstrate a potential of genetically produced LF and LZ rice to be used as a substitute for antibiotics in broiler diets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042436     DOI: 10.1093/jn/132.6.1214

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  26 in total

1.  Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain.

Authors:  Somen Nandi; Dorice Yalda; Stephen Lu; Zivko Nikolov; Ryo Misaki; Kazuhito Fujiyama; Ning Huang
Journal:  Transgenic Res       Date:  2005-06       Impact factor: 2.788

Review 2.  Immunomodulatory effects of lactoferrin.

Authors:  Tania Siqueiros-Cendón; Sigifredo Arévalo-Gallegos; Blanca Flor Iglesias-Figueroa; Isui Abril García-Montoya; José Salazar-Martínez; Quintín Rascón-Cruz
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

3.  Production of recombinant human lysozyme in the milk of transgenic pigs.

Authors:  Jia Tong; HengXi Wei; XiaoFang Liu; WenPing Hu; MingJun Bi; YuanYuan Wang; QiuYan Li; Ning Li
Journal:  Transgenic Res       Date:  2010-06-12       Impact factor: 2.788

4.  Generation of bi-transgenic pigs overexpressing human lactoferrin and lysozyme in milk.

Authors:  Dan Cui; Jia Li; Linlin Zhang; Shen Liu; Xiao Wen; Qiuyan Li; Yaofeng Zhao; Xiaoxiang Hu; Ran Zhang; Ning Li
Journal:  Transgenic Res       Date:  2014-09-19       Impact factor: 2.788

5.  High-level expression of bioactive recombinant human lysozyme in the milk of transgenic mice using a modified human lactoferrin BAC.

Authors:  Shen Liu; Xiangqing Li; Dan Lu; Shengzhe Shang; Meili Wang; Min Zheng; Ran Zhang; Bo Tang; Qiuyan Li; Yunping Dai; Ning Li
Journal:  Transgenic Res       Date:  2011-07-30       Impact factor: 2.788

6.  Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction.

Authors:  Fedde Groot; Teunis B H Geijtenbeek; Rogier W Sanders; Christopher E Baldwin; Marta Sanchez-Hernandez; René Floris; Yvette van Kooyk; Esther C de Jong; Ben Berkhout
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Consumption of pasteurized human lysozyme transgenic goats' milk alters serum metabolite profile in young pigs.

Authors:  Dottie R Brundige; Elizabeth A Maga; Kirk C Klasing; James D Murray
Journal:  Transgenic Res       Date:  2009-10-22       Impact factor: 2.788

8.  Consumption of transgenic cows' milk containing human lactoferrin results in beneficial changes in the gastrointestinal tract and systemic health of young pigs.

Authors:  Caitlin A Cooper; Kathryn M Nelson; Elizabeth A Maga; James D Murray
Journal:  Transgenic Res       Date:  2012-10-17       Impact factor: 2.788

9.  Effects of dietary supplementation with lysozyme during late gestation and lactation stage on the performance of sows and their offspring.

Authors:  Shengyu Xu; Jiankai Shi; Xiaoling Shi; Yanpeng Dong; Xiaoling Wu; Zimei Li; Zhengfeng Fang; Yan Lin; Lianqiang Che; Jian Li; Bin Feng; Jianping Wang; Yanping Shen
Journal:  J Anim Sci       Date:  2018-11-21       Impact factor: 3.159

Review 10.  Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic.

Authors:  Patrizia Ferraboschi; Samuele Ciceri; Paride Grisenti
Journal:  Antibiotics (Basel)       Date:  2021-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.